SIGA TECHNOLOGIES COM USD0.0001 (SIGA)

3.23
OTC Markets
Prev Close 3.23
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.20 / 3.35
Exchange OTC Markets
Shares Outstanding 54.28B
Market Cap 176.42M
Div & Yield N.A. (N.A)

Latest News

SIGA Announces Dr. Phil Gomez Joins Company As New CEO, Dr. Eric Rose To Serve As Executive Chairman Of The Board

SIGA Announces Dr. Phil Gomez Joins Company As New CEO, Dr. Eric Rose To Serve As Executive Chairman Of The Board

SIGA Technologies, Inc. (SIGA) (OTCMKTS:SIGA) today announced that Dr.

SIGA Announces Oct. 12 Record Date For Rights Offering

SIGA Announces Oct. 12 Record Date For Rights Offering

SIGA Technologies, Inc. (SIGA) (OTCMKTS:SIGA) today announced that the Record Date for the Company's previously announced proposed rights offering (the "Rights Offering") is October 12 th, 2016.

SIGA Announces Bankruptcy Court Approval Of Transaction Under Which SIGA Will Pay PharmAthene Claim In Full

SIGA Announces Bankruptcy Court Approval Of Transaction Under Which SIGA Will Pay PharmAthene Claim In Full

SIGA Technologies, Inc. (SIGA) (OTCMKTS:SIGA),SIGA Technologies, Inc.

SIGA Announces Completion Of Enrollment And Dosing In The Final Cohort Of Phase III Study Of TPOXX™ (tecovirimat)

SIGA Announces Completion Of Enrollment And Dosing In The Final Cohort Of Phase III Study Of TPOXX™ (tecovirimat)

SIGA Technologies, Inc. (SIGA) (OTCMKTS:SIGA), a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, announced completion of enrollment and dosing in...

SIGA Announces Data Safety Monitoring Board (DSMB) Approval To Complete Subject Enrollment In The Final Cohort Of Phase III Study Of TPOXX™ (tecovirimat)

SIGA Announces Data Safety Monitoring Board (DSMB) Approval To Complete Subject Enrollment In The Final Cohort Of Phase III Study Of TPOXX™ (tecovirimat)

SIGA Technologies, Inc. (SIGA) (OTCMKTS:SIGA), a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, announced that it has received approval from its...

SIGA Announces Enrollment Of First Patients In The Final Cohort Of Phase III Study Of Tecovirimat

SIGA Announces Enrollment Of First Patients In The Final Cohort Of Phase III Study Of Tecovirimat

SIGA Technologies, Inc. (SIGA) (OTCMKTS:SIGA), a company specializing in the development of pharmaceutical agents to combat bio-warfare pathogens, announced today that it has begun enrolling the second and final cohort of...

SIGA Technologies Receives NASDAQ Delisting Notification

SIGA Technologies Receives NASDAQ Delisting Notification

SIGA Technologies, Inc. ("SIGA"), a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, announced that it received a letter today from the Hearings...

SIGA Technologies, Inc. Appeals Judgment Of Delaware Court Of Chancery

SIGA Technologies, Inc. Appeals Judgment Of Delaware Court Of Chancery

SIGA Technologies, Inc. (Nasdaq:SIGA), a company operating under the protection of the United States Bankruptcy Court for the Southern District of New York and specializing in the development and commercialization of...

Delaware Court Decision Regarding SIGA Technologies, Inc.

Delaware Court Decision Regarding SIGA Technologies, Inc.

SIGA Technologies, Inc. (Nasdaq:SIGA), a company operating under the protection of the United States Bankruptcy Court for the Southern District of New York and specializing in the development and commercialization of...

SIGA Technologies, Inc. Receives Bankruptcy Court Approval For First-Day Motions In Connection With Chapter 11 Case

SIGA Technologies, Inc. Receives Bankruptcy Court Approval For First-Day Motions In Connection With Chapter 11 Case

SIGA Technologies, Inc. (NASDAQ:SIGA), a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, announced today that it has received Bankruptcy Court...

SIGA Technologies, Inc. Files For Chapter 11 Reorganization

SIGA Technologies, Inc. Files For Chapter 11 Reorganization

SIGA Technologies, Inc. (NASDAQ:SIGA), a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, announced today that it has filed a voluntary petition...

4 Under-$10 Stocks to Trade for Breakouts

4 Under-$10 Stocks to Trade for Breakouts

These stocks under $10 are within range of triggering breakout trades.

Why SIGA Technologies (SIGA) Stock Plunged to a One-Year Low Today

Why SIGA Technologies (SIGA) Stock Plunged to a One-Year Low Today

SIGA Technologies (SIGA) plunged to a 52-week low of $1.62 on Monday after a Delaware court ruled the company must pay a lump sum in damages to PharmAthene (PIP).

Deal Or No Deal: 6 Stocks Under 5 Bucks With Buy Ratings

Deal Or No Deal: 6 Stocks Under 5 Bucks With Buy Ratings

James Dennin, Kapitall: We looked for investing deals based on analyst ratings and P/E ratios, to find you 6 stocks under 5 [...]

SIGA: Insiders Vs. Shorts

SIGA: Insiders Vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 08/30/2013 settlement date, and SIGA Technologies Inc is one of the most shorted stocks of the Russell 3000, based on 55.19 "days to cover" versus the median component at 5.87. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These under-$10 stocks look poised to trade higher from current levels.

4 Biotech Stocks Under $10 Making Big Moves

4 Biotech Stocks Under $10 Making Big Moves

Keep these biotech stocks on your radar.